Inivata to present at the Biotech Showcase in San Francisco
Company will also participate in
“Generation Genome and Industrial Strategy: Leveraging UK Leadership in Genomics” Panel
Research Triangle Park, NC and Cambridge, UK, January 4, 2018 — Inivata, a global clinical cancer genomics company utilizing an industry-leading liquid biopsy platform to transform patient care, today announces that Michael Stocum, CEO of Inivata, will present a company update at the Biotech Showcase™ 2018 held in San Francisco 8 – 10 January. The presentation will take place at 11:00 PST on Tuesday, 9 January at the Hilton San Francisco, Union Square.
Michael Stocum will also participate in the Generation Genome and Industrial Strategy: Leveraging UK Leadership in Genomics panel, held in partnership with the UK BioIndustry Association, Genomics England and MedCity. The panel will be held from 14:00 – 14:45 on 8 January at Parc 55, Level 3, Market Street. The panel will bring together representatives from Genomics England, technology partners, SMEs and the venture community to debate the opportunities and challenges that will shape the growth of the UK’s genomics industry and its impact worldwide. Inivata is currently collaborating with Genomics England as part of the 100,000 Genomes Project, to assess the quality of blood plasma samples and explore the potential of liquid biopsy to improve disease management and cancer patient outcomes.Discover more news